MedPath

广州白云山星群(药业)股份有限公司

Ownership
-
Established
1993-06-18
Employees
-
Market Cap
-
Website
http://www.xingqun.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

119

NMPA:119

Drug Approvals

胆舒软胶囊

Approval Number
国药准字Z20080605
Approval Date
Mar 14, 2023
NMPA

Malotilate Emulsion

Product Name
辛益甘
Approval Number
国药准字H20061241
Approval Date
Mar 14, 2023
NMPA

Diphenhydramine Hydrochloride Softgels

Product Name
盐酸苯海拉明软胶囊
Approval Number
国药准字H20070315
Approval Date
Mar 2, 2022
NMPA

Diphenhydramine Hydrochloride Softgels

Product Name
盐酸苯海拉明软胶囊
Approval Number
国药准字H20070314
Approval Date
Mar 2, 2022
NMPA

Zinc Gluconate Oral Solution

Product Name
葡萄糖酸锌口服溶液
Approval Number
国药准字H20059936
Approval Date
Jun 19, 2020
NMPA

Taurine Granules

Product Name
牛磺酸颗粒
Approval Number
国药准字H19999254
Approval Date
May 15, 2020
NMPA

草豆蔻酊

Approval Number
国药准字Z44022210
Approval Date
May 15, 2020
NMPA

复方龙胆酊

Approval Number
国药准字Z44022246
Approval Date
May 15, 2020
NMPA

Concentrated Divitamins and Sodium Phosphate Syrup

Product Name
浓维磷糖浆
Approval Number
国药准字H44024814
Approval Date
May 13, 2020
NMPA

小儿清咽颗粒

Approval Number
国药准字Z44022259
Approval Date
May 13, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.